Related Experiment Video
Updated: Jun 26, 2026
11:58
Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
Published on: June 25, 2014
Immune barriers to successful gene therapy
Te-Lang Wu1, Hildegund C J Ertl
1University of Pennsylvania School of Medicine, The Wistar Institute, 3601 Spruce St, Philadelphia, PA 19104, USA.
Trends in Molecular Medicine
|December 23, 2008
Summary
Overcoming immune responses to viral vectors is key for gene replacement therapy. Harnessing regulatory T cells (Tregs) and tolerogenic dendritic cells (DCs) may reduce these barriers.
Area of Science:
- Immunology
- Gene Therapy
Background:
- Immune responses to viral vectors are a major hurdle for gene replacement therapy.
- Both innate and adaptive immunity impede sustained gene transfer.
- Regulatory T cells (Tregs) and tolerogenic dendritic cells (DCs) play crucial roles in immune regulation.
Purpose of the Study:
- To discuss challenges in overcoming immune barriers in gene therapy.
- To explore strategies for circumventing immune responses against viral vectors and transgene products.
Main Methods:
- Review of current knowledge in immunoregulatory pathways.
- Analysis of potential applications of Tregs and DCs in gene therapy.
Main Results:
- Significant progress has been made in understanding immunoregulatory pathways.
- Tregs and DCs offer potential avenues to mitigate immune responses.
Conclusions:
- Leveraging immunological insights is crucial for advancing gene therapy.
- Strategies targeting immune responses are essential for successful long-term gene replacement therapy.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:40Cell-mediated Immune Responses
Overview
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...